Print this page    •   Back to Web version of article

New 300 mg Reyataz Capsule Approved

October 23, 2006

On October 16, 2006, the Food and Drug Administration approved a new 300 mg capsule form of Reyataz (atazanavir).

Reyataz is now available as 100mg, 150 mg, 200 mg, and the new 300 mg capsules.

The new 300 mg capsules give treatment-experienced patients the option to take either one 300 mg capsule, or two 150 mg capsules of Reyataz, once daily plus ritonavir 100 mg once daily, with food.

The recommended dose for treatment-naive patients remains unchanged and is Reyataz 400 mg (two 200mg capsules) once daily with food.

Reyataz is a product of Bristol-Myers Squibb.




This article was provided by U.S. Food and Drug Administration. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art38522.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.